Oramed Pharmaceuticals Inc. (TLV:ORMP)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
713.70
+13.40 (1.91%)
Aug 21, 2025, 5:24 PM IDT

Oramed Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20212016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Aug '21 2016 - 2020
2-1.342.72.712.7
Upgrade
Revenue Growth (YoY)
---50.42%-0.33%0.33%-0.33%
Upgrade
Cost of Revenue
1.99-----
Upgrade
Gross Profit
0.01-1.342.72.712.7
Upgrade
Selling, General & Admin
6.746.468.1415.6612.585.94
Upgrade
Research & Development
6.946.328.9727.6427.1120.99
Upgrade
Operating Expenses
13.6912.7817.1143.339.6926.93
Upgrade
Operating Income
-13.67-12.78-15.77-40.6-36.98-24.22
Upgrade
Interest Expense
--0.85-2.04---
Upgrade
Interest & Investment Income
3.9958.173.570.470.35
Upgrade
Currency Exchange Gain (Loss)
0.170.17-0.120.18-0.03-0
Upgrade
Other Non Operating Income (Expenses)
0.22-0.04-1.54-0.01-0.01-0.01
Upgrade
EBT Excluding Unusual Items
-9.29-8.5-11.3-36.86-36.55-23.88
Upgrade
Gain (Loss) on Sale of Investments
-12.92-7.4216.39-0.81-0.220.9
Upgrade
Pretax Income
-22.22-15.925.09-37.66-36.77-22.99
Upgrade
Income Tax Expense
2.013.18-0.1--
Upgrade
Earnings From Continuing Operations
-24.22-19.15.09-37.76-36.77-22.99
Upgrade
Minority Interest in Earnings
0.060.040.441.21.760.75
Upgrade
Net Income
-24.16-19.065.53-36.56-35-22.24
Upgrade
Net Income to Common
-24.16-19.065.53-36.56-35-22.24
Upgrade
Shares Outstanding (Basic)
414140393728
Upgrade
Shares Outstanding (Diluted)
414141393728
Upgrade
Shares Change (YoY)
-0.21%0.65%4.02%5.08%30.36%16.71%
Upgrade
EPS (Basic)
-0.59-0.470.14-0.94-0.94-0.78
Upgrade
EPS (Diluted)
-0.60-0.480.14-0.94-0.94-0.78
Upgrade
Free Cash Flow
-16.09-8.43-10.55-28.41-33.39-21.56
Upgrade
Free Cash Flow Per Share
-0.39-0.21-0.26-0.73-0.90-0.76
Upgrade
Gross Margin
0.65%-100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-683.65%--1176.79%-1501.96%-1363.50%-896.15%
Upgrade
Profit Margin
-1208.10%-412.31%-1352.61%-1290.71%-822.72%
Upgrade
Free Cash Flow Margin
-804.45%--787.24%-1051.20%-1231.31%-797.48%
Upgrade
EBITDA
-13.53-12.59-15.57-40.54-36.92-24.15
Upgrade
D&A For EBITDA
0.140.190.20.060.050.08
Upgrade
EBIT
-13.67-12.78-15.77-40.6-36.98-24.22
Upgrade
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.